je.st
news
Eagle Pharmaceuticals: Even After 350% Rally, Shares Have Upside
2015-04-23 13:47:49| Biotech - Topix.net
The main catalyst for this huge rise was a game changing partnership around its main drug candidate with generic drug powerhouse Teva Pharmaceuticals. Although it is prudent to take some profits, further upside remains as earnings estimates explode to the upside and the stock is still cheap at 12 times 2016's projected earnings.
Tags: have
shares
eagle
rally
Category:Biotechnology and Pharmaceuticals